Beneficial effects of local profound hypothermia and the possible mechanism after experimental spinal cord injury in rats

Journal of Spinal Cord Medicine

Volumn 39, Issue 2, 2016, Pages 220-228

  Xu, Xiaoyu ^a   Li, Ning ^a   Zhu, Lin ^a   Zhou, Yuan ^a   Cheng, Huilin ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Profound hypothermia; RhoA; ROCK; Spinal cord injury

Indexed keywords

BREVICAN; FAST BLUE; LUXOL FAST BLUE; MESSENGER RNA; NEUROCAN; NG2 PROTEIN; PROTEIN; PROTEIN NOGO A; RHO KINASE; RHO KINASE II; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; PROTEIN NOGO;

ADULT; ADULT ANIMAL; ANEURYSM CLIP; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BBB SCORE; BIELSCHOWSKY SILVER STAIN; CONTROLLED STUDY; DEMYELINATION; DOWN REGULATION; EXPERIMENTAL SPINAL CORD INJURY; GENE EXPRESSION; HINDLIMB; LOCAL PROFOUND HYPOTHERMIA; MALE; MOTOR PERFORMANCE; NERVE FIBER REGENERATION; NONHUMAN; PROFOUND INDUCED HYPOTHERMIA; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SCORING SYSTEM; SILVER STAINING; WARMING; WESTERN BLOTTING; ANIMAL; AXON; CONVALESCENCE; GENETICS; INDUCED HYPOTHERMIA; INNERVATION; METABOLISM; NERVE REGENERATION; PHYSIOLOGY; SPINAL CORD INJURIES; SPRAGUE DAWLEY RAT;

ANIMALS; AXONS; BREVICAN; DOWN-REGULATION; HINDLIMB; HYPOTHERMIA, INDUCED; MALE; NERVE REGENERATION; NEUROCAN; NOGO PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SPINAL CORD INJURIES;

EID: 84963995176     PISSN: 10790268     EISSN: 20457723     Source Type: Journal    
DOI: 10.1179/2045772315Y.0000000051     Document Type: Article

References (46)

1. John WM, Xiaozhong L, Yun Q, Su L, Shannon KM, Dorothy T, et al. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med 1999;12(1): 1410-2.
2. Asamoto S1, Sugiyama H, Doi H, Iida M, Nagao T, Matsumoto K. Hyperbaric oxygen (HBO) therapy for acute traumatic cervical spinal cord injury. Spinal Cord 2000;38(3):538-40.
3. Nikolov NM, Cunningham AJ. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346(8):549-56.
4. Conrad MF, Crawford RS, Davison JK, Cambria RP. Thoracoabdominal aneurysm repair: A 20-year perspective. Ann Thorac Surg 2007;83(2):856-61, 890-2.
5. Tabayashi K, Saiki Y, Kokubo H, Takahashi G, Akasaka J, Yoshida S, et al. Protection from postischemic spinal cord injury by perfusion cooling of the epidural space during most or all of a descending thoracic or thoracoabdominal aneurysm repair. Gen Thorac Cardiovasc Surg 2010;58(5):228-34.
6. Hsu CC, Kwan GN, Van Driel ML, Rophael JA. Distal aortic perfusion during thoracoabdominal aneurysm repair for prevention of paraplegia. Cochrane Database Syst Rev 2012;3:CD8197.
7. Bricolo A, Ore GD, Da PR, Faccioli F. Local cooling in spinal cord injury. Surg Neurol 1976;6(2):101-6.
8. Ha KY, Kim YH. Neuroprotective effect of moderate epidural hypothermia after spinal cord injury in rats. Spine (Phila Pa 1976) 2008;33(19):2059-65.
9. Hansebout RR, Hansebout CR. Local cooling for traumatic spinal cord injury: Outcomes in 20 patients and review of the literature. J Neurosurg Spine 2014;20(5):550-61.
10. Schumacher PA, Siman RG, Fehlings MG. Pretreatment with calpain inhibitor CEP-4143 inhibits calpain I activation and cytoskeletal degradation, improves neurological function, and enhances axonal survival after traumatic spinal cord injury. J Neurochem 2000;74(4):1646-55.
11. Eldadah BA, Faden AI. Caspase pathways, neuronal apoptosis, and CNS injury. J Neurotrauma 2000;17(10):811-29.
12. Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L. Acute inflammatory response in spinal cord following impact injury. Exp Neurol 1998;151(1):77-88.
13. Charles HT. Update on the pathophysiology and pathology of acute spinal cord injury. Brain Pathol 1995;5(4):407-13.
14. Craenen G, Jeftinija S, Grants I, Lucas JH. The role of excitatory amino acids in hypothermic injury to mammalian spinal cord neurons. J Neurotrauma 1996;13(12):809-18.
15. Schwab ME, Bartholdi D. Degeneration and regeneration of axons in the lesioned spinal cord. Physiol Rev 1996;76(2):319-70.
16. Fidler PS, Schuette K, Asher RA, Dobbertin A, Thornton SR, Calle-Patino Y, et al. Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: The major axon-inhibitory proteoglycan is NG2. J Neurosci 1999;19(20): 8778-88.
17. Friedlander DR, Milev P, Karthikeyan L, Margolis RK, Margolis RU, Grumet M. The neuronal chondroitin sulfate proteoglycan neurocan binds to the neural cell adhesion molecules Ng-CAM/L1/NILE and N-CAM, and inhibits neuronal adhesion and neurite outgrowth. J Cell Biol 1994;125(3):669-80.
18. Quaglia X, Beggah AT, Seidenbecher C, Zurn AD. Delayed priming promotes CNS regeneration post-rhizotomy in Neurocan and Brevican-deficient mice. Brain 2008;131(1):240-49.
19. Jones LL, Margolis RU, Tuszynski MH. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan and versican are differentially regulated following spinal cord injury. Exp Neurol 2003;182(2):399-411.
20. Xiufeng T, Jeannette ED, Stephen JD. Changes in distribution, cell associations, and protein expression levels of NG2, Neurocan, Phosphacan, Brevican, Versican V2, and Tenascin-C during acute to chronic maturation of spinal cord scar tissue. J Neurosci Res 2003;71(3):427-44.
21. Cafferty WB, Strittmatter SM. The Nogo-Nogo receptor pathway limits a spectrum of adult CNS axonal growth. J Neurosci 2006; 26(47):12242-50.
22. Maio SC, Andrea BH, Marjan EV, Marcus F, Lisa S, Adrian AS, et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 2000; 403(6768):434-9.
23. Hunt D, Coffin RS, Prinjha RK, Campbell G, Anderson PN. Nogo-A expression in the intact and injured nervous system. Mol Cell Neurosci 2003;24(4):1083-102.
24. XingxingW, Soo-Jin C, Helen T, Timothy V, Charles AG, Stephen MS. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci. 2002; 22(13):5505-15.
25. Monnier PP, Sierra A, Schwab JM, Henke-Fahle S, Mueller BK. The Rho/ROCK pathway mediates neurite growthinhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol Cell Neurosci 2003;22(3): 319-30.
26. Barbara N, Thomas O, Jens F, R.Anne M, Christine EB. Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J Neurosci 2002;22(23):10368-76.
27. Joo-Kyung Sung, Liyan Miao, John WC, Lixin H. A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat. Brain Research 2003;959(1):29-38.
28. Masahito H , Masakazu T, Kazuhiko W, Atsushi N, Teruhide T, Yoshio S, et al. Protein kinase inhibition by fasudil hydrochloride promotes neurological recovery after spinal cord injury in rats. J Neurosurg 2003;93(1 Suppl):94-101.
29. John D, Ankur RP, Xiao-Li Y, Robert B, Craig MP, Shuxin Li. A molecular mechanism for ibuprofen mediated RhoA inhibition in neurons. J Neurosci 2010;30(3):963-72.
30. Anja H, Fred H, Ingo J, Seija L, Uwe-Karsten H, Wolfgang B, et al. Inhibition of Rho-dependent pathways by Clostridium botulinum C3 protein induces a proinflammatory profile in microglia. Glia 2008;56(11):1162-75.
31. Alyson EF, Bayan TT, Stephen MS. Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci 2003;23(4):1416-23.
32. Watzlawick R, Sena ES, Dirnagl U, Brommer B, Kopp MA, Macleod MR, et al. Effect and reporting bias of RhoA/ROCKblockade intervention on locomotor recovery after spinal cord injury: A systematic review and meta-analysis. JAMA Neurol 2014;71(1):91-9.
33. Merkler D, Metz GA, Raineteau O, Dietz V, Schwab ME, Fouad K. Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor Nogo-A. J Neurosci 2001;21(10):3665-73.
34. Elizabeth JB, Lawrence DM, Reena JP, Von RK, Gavin SB, Preena NP, et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002;416(6881):636-40.
35. Ning L, Lei T, Wei W, Huchen L, Yuan Z, Xiaoyu X, et al. Regional hypothermia inhibits spinal cord somatosensory-evoked potentials without neural damage in uninjured rats. J Neurotrauma 2013;30(15):1325-33.
36. Basso DM, Beattie MS, Bresnahan JC. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 1995;12(1):1-21.
37. Stephen JAD, Michael TFitch, Stacey PM, Alison KH, Geoffrey R, Jerry S. Regeneration of adult axons in white matter tracts of the central nervous system. Nature 1997;390(6661):680-3.
38. Takeshi S, Shino S, Hiroshi Y, Masanori T. Neuroprotection following mild hypothermia after spinal cord ischemia in rats. J Vasc Surg 2013;57(1):173-81.
39. Morino T, Ogata T, Takeba J, Yamamoto H. Microglia inhibition is a target of mild hypothermic treatment after the spinal cord injury. Spinal Cord 2008;46(6):425-31.
40. Liqun L. Rho GTPases in neuronal morphogenesis. Nat Rev Neurosci 2000;1(3):173-80.
41. Soliman HM, Mercan D, Lobo SS, Mélot C, Vincent JL. Development of ionized hypomagnesemia is associated with higher mortality rates. Crit Care Med 2003;31(4):1082-87.
42. Melhuish T. Linking hypothermia and hyperglycemia. Nurs Manage 2009;40(12):42-5.
43. Lenhardt R. The effect of anesthesia on body temperature control. Front Biosci (Schol Ed) 2010;2:1145-54.
44. Amar AP, Levy ML. Surgical controversies in the management of spinal cord injury. J Am Coll Surg 1999;188(5):550-66.
45. Yu WR, Westergren H, Farooque M, Holtz A, Olsson Y. Systemic hypothermia following compression injury of rat spinal cord: Reduction of plasma protein extravasation demonstrated by immunohistochemistry. Acta Neuropathol 1999; 98(1):15-21.
46. Shibuya S, Miyamoto O, Janjua NA, Itano T, Mori S, Norimatsu H. Post-traumatic moderate systemic hypothermia reduces TUNEL positive cells following spinal cord injury in rat. Spinal Cord 2004;42(1):29-34.